Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression

Psychiatric Services

Volumn 60, Issue 4, 2009, Pages 439-444

  Valenstein, Marcia ^a,c   Eisenberg, Daniel ^b   McCarthy, John F ^a,c   Austin, Kren L ^a   Ganoczy, Dara ^a   Kim, Hyungjin Myra ^a,b   Zivin, Kara ^a,c   Piette, John D ^a,d   Olfson, Mark ^e   Blow, Frederic C ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH RESEARCH; MENTAL HEALTH SERVICE; PATIENT MONITORING; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE; VETERAN;

EID: 65249094254     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.4.439     Document Type: Article

References (36)

1. Zivin K, Kim HM, McCarthy JF, et al: Suicide mortality among individuals receiving treatment for depression in the Veterans Affairs health system: associations with patient and treatment setting characteristics. American Journal of Public Health 97:2193-2198, 2007
2. Simon GE, VonKorff M: Suicide mortality among patients treated for depression in an insured population. American Journal of Epidemiology 47:155-160, 1998
3. Bostwick JM, Pankratz VS: Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry 157:1925-1932, 2000
4. Harris EC, Barraclough B: Suicide as an outcome for mental disorders: a meta- analysis. British Journal of Psychiatry 170:205-228, 1997
5. Pokorny AD: Prediction of suicide in psychiatric patients: report of a prospective study. Archives of General Psychiatry 40:249-257, 1983
6. Hoyer EH, Olesen AV, Mortensen PB: Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973-1993. Journal of Affective Disorders 78:209-217, 2004
7. Desai RA, Dausey DJ, Rosenheck RA: Mental health service delivery and suicide risk: the role of individual patient and facility factors. American Journal of Psychiatry 162:311-318, 2005
8. Jick H, Kaye JA, Jick SS: Antidepressants and the risk of suicidal behaviors. JAMA 292:338-343, 2004
9. FDA Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications. Silver Spring, Md, US Food and Drug Administration, Oct 15, 2004. Available at www.fda.gov
10. FDA Public Health Advisory: Suicidality in Adults Being Treated With Antidepressant Medication, Silver Spring, Md, US Food and Drug Administration, June 30, 2005. Available at www.fda.gov
11. Valenstein M, Kim HM, Ganoczy D, et al: Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. Journal of Affective Disorders 112:50-58, 2009
12. FDA Public Health Advisory: Class Suici- dality Labeling Language for Antidepres- sants. Silver Spring, Md, US Food and Drug Administration, Feb 3, 2005. Available at www.fda.gov/cder/drug/antidepres sants/PI-template.pdf
13. Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 157(suppl 4):1-45, 2000
14. Depression Guideline Panel: Depression in Primary Care: Vol 2. Treatment of Major Depression. Clinical Practice Guideline, no 5. AHCPR pub no 93-0551. Rockville, Md, Agency for Health Care Policy and Research, 1993
15. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287:203-209, 2002
16. Libby AM, Brent DA, Morrato EH, et al: Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 164:884-891, 2007
17. Valuck RJ, Libby AM, Orton HD, et al: Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry 164:1198-1205, 2007
18. Olfson M, Marcus SC, Druss BG: Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry 65:94-101, 2008
19. Cohen JT, Neumann PJ, Weinstein MC: Does preventive care save money? Health economics and the presidential candidates. New England Journal of Medicine 358:661-663, 2008
20. Bridges CB, Thompson WW, Meltzer MI, et al: Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284:1655-1663, 2000
21. Kerlikowske K, Salzmann P, Phillips KA, et al: Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA 282:2156-2163, 1999
22. Mohr PE, Neumann PJ, Franco SJ, et al: The case for daily dialysis: its impact on costs and quality of life. American Journal of Kidney Diseases 37:777-789, 2001
23. Selby-Harrington M, Sorenson JR, Quade D, et al: Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits. American Journal of Public Health 85:1412-1417, 1995
24. Stout NK, Rosenberg MA, Trentham-Dietz A, et al: Retrospective cost-effectiveness analysis of screening mammography. Journal of the National Cancer Institute 98:774-782, 2006
25. Health Plan Employer Data and Information Set. Washington, DC, National Committee on Quality Assurance, 2006
26. Phibbs CS, Bhandari A, Yu W, et al: Estimating the costs of VA ambulatory care. Medical Care Research and Review 60(suppl 3):54S-73S, 2003
27. Sloan KL, Montez-Rath ME, Spiro A III, et al: Development and validation of a psychiatric case-mix system. Medical Care 44:568-580, 2006
28. Yu W, Wagner TH, Barnett PG: Determinants of cost among people who died in VA nursing homes. Medical Care Research and Review 63:477-498, 2006
29. Liu CF, Hedrick SC, Chaney EF, et al: Cost-effectiveness of collaborative care for depression in a primary care veteran population. Psychiatric Services 54:698-704, 2003
30. Von Korff M, Katon W, Bush T, et al: Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosomatic Medicine 60:143-149, 1998
31. Simon GE, VonKorff M, Rutter C, et al: Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 320:550-554, 2000
32. Budget of the United States Government, Fiscal Year 2006. Washington, DC, Department of Veterans Affairs, 2006. Available at georgewbush-whitehouse. archives.gov/omb/ budget/fy2006/veterans.html
33. Katon W, Von Korff M, Lin E, et al: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273:1026-1031, 1995
34. Mann JJ, Apter A, Bertolote J, et al: Suicide prevention strategies: a systematic review. JAMA 294:2064-2074, 2005
35. Stettin GD, Yao J, Verbrugge RR, et al: Frequency of follow-up care for adult and pediatric patients during initiation of anti- depressant therapy. American Journal of Managed Care 12:453-461, 2006
36. Liu CFC-F, Fortney JJ, Vivell SS, et al: Time allocation and caseload capacity in telephone depression care management. American Journal of Managed Care 13:652-660, 2007